oncogenic HPV

oncogenic HPV

A human papillomavirus–HPV genotype, especially types 16, 18, but also types 31, 33, and 51, which is pathogenically linked to intraepithelial neoplasia–eg, uterine cervix, termed CIN. See CIN, HPV.
Mentioned in ?
References in periodicals archive ?
Efficacy of human papillomavirus (HPV) - 16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types ( PATRICIA ): final analysis of a doubleblind, randomised study in young women.
The Need for Societal Investment to Improve Cervical Cancer Outcomes in Nigeria: A commentary
In addition, oestrogen acts as an anti-apoptotic agent permitting proliferation of cells infected with oncogenic HPV.
PREVALENCE OF HUMAN PAPILLOMA VIRUS AND ITS ASSOCIATED RISK FACTORS IN WOMEN WITH ABNORMAL CYTOLOGY AT A TERTIARY CARE HOSPITAL OF NORTH INDIA
In the past two decades, Human Papilloma Virus (HPV) strains have been identified as a causative agent in cervical cancer in particular with high grade oncogenic HPV genotypes, such as HPV-16 and HPV-18, along with some other factors predispose women to cancer10,11.
AWARENESS AND KNOWLEDGE REGARDING RISK FACTORS AND COMMON SYMPTOMS OF CERVICAL CANCER AMONG FEMALE STUDENTS OF RAWALPINDI
Together, these 7 oncogenic HPV types are responsible for approximately 90% of HPV-related cancers, including cervical, anal, oropharyngeal, vaginal, and vulvar cancer.
It is time for HPV vaccination to be considered part of routine preventive health care
The 9-valent vaccine would prevent a broader range of oncogenic HPV types.
Anal cancer in HIV-infected patients: To screen or not?
Local data from Africa on the relationship between oncogenic HPV types, immune status and cervical preinvasive lesions are also incomplete.
Oncogenic and incidental HPV types associated with histologically confirmed cervical intraepithelial neoplasia in HIV-positive and HIV-negative South African women
This prospective multicenter study, called IDAHO (Intgration de lADN des HPV Oncognes, or integration of oncogenic HPV DNA), will involve 3,500 patients to be treated at 11 leading French gynecology hospitals.
France : Genomic Vision and Reims University Hospital Launch Clinical Study to Establish New Screening Tool for Early Detection and Prevention of Cervical Cancer
Although there are approximately a dozen oncogenic HPV types, HPV 16 and 18 are the most common HPV types and are found in approximately 70% of cervical cancers.
Molecular localization of human papillomaviru-18 (HPV-18) in tissues from thyroid carcinoma in Mid-Euphrate-Iraq
If human papillomavirus vaccines could be delivered as one dose, while retaining their efficacy against the most oncogenic HPV types 16 and 18, we could substantially decrease the global burden of cervical cancer, particularly in resource-poor settings where an annual vaccination program might be difficult to sustain.
Single HPV vaccine dose appears as effective as full course
The bivalent vaccine protects against HPV-16 and -18, the most common oncogenic HPV types, which are responsible for [approximately equal to]70% of HPV-associated cervical cancers and a large proportion of other HPV-related cancers (1).
Monitoring effect of human papillomavirus vaccines in US population, emerging infections program, 2008-2012
Although evidence for the efficacy of the HPV vaccines in the prevention of oral infection with oncogenic HPV types is still limited, there is biologic plausibility of potential effectiveness of these vaccines against head and neck cancers (8).
Oral human papillomavirus infection among drug users in Puerto Rico
3% of the samples were high-risk oncogenic HPV (HR-HPV) and 66.
Uncommon non-oncogenic HPV genotypes, TP53 and MDM2 genes polymorphisms in HIV-infected women in southern Brazil

Medical browser ?
Full browser ?